Sort
21,453 grants matching “tuberculosis”
Tanzania Infectious Disease Research Training Program
$141,717Wafaie W Fawzi · Harvard School Of Public Health · D43 · FY2008 · TW
Research Training on Intracellular Pathogens
$141,717Kenneth D Stuart · Seattle Biomedical Research Institute · D43 · FY2008 · TW
The South African Infectious Disease Clinical Research Training Program
$141,717Gregory D Hussey · University Of Cape Town · D43 · FY2008 · TW
Quantify and prepare for the double infectious and non-communicable disease burden in Zimbabwe.
$141,650Timothy Hallett · Imperial College Of Science, Technology And Medicine · R21 · FY2017 · AG
Test and Treat TB: A Proof of Concept Trial in South Africa
$141,619Ingrid Valerie Bassett · Massachusetts General Hospital · R21 · FY2015 · AI
MENTORING MULTIDISCIPLINARY PATIENT-ORIENTED RESEARCH IN ENGAGEMENT IN HIV CARE
$141,410Elvin H. Geng · Washington University · K24 · FY2024 · AI
MENTORING MULTIDISCIPLINARY PATIENT-ORIENTED RESEARCH IN ENGAGEMENT IN HIV CARE
$141,348Elvin H. Geng · Washington University · K24 · FY2025 · AI
Community Transmission of Tuberculosis Urban Africa
$141,326Christopher C. Whalen · University Of Georgia · R01 · FY2019 · AI
Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents
$141,173Erick Strauss · Stellenbosch University · R01 · FY2019 · AI
Ethanol-induced dysfunction of lung anti-microbial activity via vitamin D modulat
$140,990Michael L McCaskill · Tulane University Of Louisiana · K01 · FY2016 · HL
Molecular Pathogenesis of Infectious Diseases
$140,952Andres Vazquez-Torres · University Of Colorado Denver · T32 · FY2018 · AI
Molecular Epidemiology and Key Issues of Foodborne Pathogens in Eastern Africa
$140,822Wondwossen A. Gebreyes · Ohio State University · D43 · FY2014 · TW
Data Science Core
$140,817Shuyi Ma · University Of Washington · P30 · FY2025 · AI
SYNTHETIC MODELS FOR MOLYBDOENZYMES ACTIVE SITES AND FUNCTIONS
$140,800Feifei Li · New Mexico State University Las Cruces · SC2 · FY2017 · GM
The Public Health Impact of ART in South Africa
$140,769Mark Nathan Lurie · Brown University · K01 · FY2008 · MH
NOVEL DRUG DESIGN AND HIGH THROUGHPUT SCREENING
$140,764Edith Porter · California State University Los Angeles · P20 · FY2006 · MD
Microbiology, Immunology, Animal Modeling and Imaging
$140,692William Ramses Bishai · Johns Hopkins University · P30 · FY2023 · AI
Clinical Predictors of weekly Rifapentine/isoniazid related adverse drug reactions during national roll-out of tuberculosis preventive therapy
$140,663Christine Sekaggya-Wiltshire · Infectious Diseases Institute · R01 · FY2024 · AI
Training in bacteriology
$140,663Jeffrey N. Weiser · University Of Pennsylvania · T32 · FY2006 · AI
Analyzing the Genetic Basis of Mtb Latency/Reactivation
$140,567Sandia Corp-Sandia National Laboratories · K25 · FY2005 · HL
Impact of SARS-CoV-2 infection on reactivation of latent Mtb infections in a Kenyan Cohort
$140,534Jesse Gitaka · Mount Kenya University · R01 · FY2022 · AI
Center of Excellence for Diabetes in Americans of Mexican Descent
$140,524Joseph B. McCormick · University Of Texas Hlth Sci Ctr Houston · P20 · FY2010 · MD
Transmission of drug-resistant tuberculosis in a South African city with a high prevalence of HIV infection
$140,506Rebecca Hafkin Berhanu · Vanderbilt University Medical Center · K08 · FY2021 · AI
Drug Abuse and NeuroAIDS in China
$140,484Johnny J He · Indiana University Indianapolis · R21 · FY2008 · DA
Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents
$140,377Erick Strauss · Stellenbosch University · R01 · FY2018 · AI